Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Janie Chiang"'
Publikováno v:
Journal of Interferon Research. 13:111-120
The pharmacokinetics and antiviral activity of recombinant human interferon-beta ser17 (Betaseron) were evaluated in African green monkeys. In one study, animals infected with simian varicella virus were administered Betaseron intravenously (i.v.), i
Publikováno v:
Pharmaceutical Research. 10:567-572
The pharmacokinetics of and biologic response modification by recombinant human interferon-βser (rIFN-βser) were evaluated in 12 healthy male volunteers. Subjects received a single intravenous (iv) injection of 90 × 106 IU of rIFN-βser followed b
Publikováno v:
Journal of Pharmacy and Pharmacology. 43:540-547
The pharmacological activity of three α1-adrenergic antagonists, prazosin, tiodazosin and WB4101 has been studied in the presence and absence of 20 μ m α1-acid glycoprotein (AAG) in rabbit aortic strips, and measured as the ability to increase the
Autor:
Nancy C. Sambol, Janie Chiang, A. M. Goodman, Leslie Z. Benet, Chui Y. Liu, Emil T. Lin, L. G. Brookes
Publikováno v:
British Journal of Clinical Pharmacology. 42:510-512
The pharmacokinetics of four single-dose treatments of the metformin administered orally (as the HCl salt) were compared in 24 healthy subjects: 500 mg and 850 mg tablets and 850 mg solution fasting and 850 mg tablet with food. Solution and tablet fo
Autor:
Leslie Z. Benet, Chui Y. Liu, Anita M. Goodman, Nancy C. Sambol, Janie Chiang, John H. Karam, Emil T. Lin, Michael O'Conner
Publikováno v:
Journal of clinical pharmacology. 36(11)
This study was conducted to assess the effect of noninsulin-dependent diabetes mellitus (NIDDM) and gender on the pharmacokinetics of metformin and to investigate whether or not metformin exhibits dose-dependent pharmacokinetics. The pharmacodynamic
Autor:
Emil T. Lin, Chui Y. Liu, Nancy C. Sambol, Janie Chiang, Martin G. Cogan, Anita M. Goodman, Leslie Z. Benet
Publikováno v:
Journal of clinical pharmacology. 35(11)
The effects of renal impairment and age on the pharmacokinetics of metformin were evaluated. The subjects, including 6 young, 12 elderly, and 3 middle-age healthy adults and 15 adults with various degrees of chronic renal impairment (CRI) each were g